cyfluthrin has been researched along with Infections, Respiratory in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (93.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| James, CL; MacDougall, C; Rafie, S | 1 |
| Bellyou, T; Hoban, DJ; Low, DE; Nichol, KA; Palatnick, L; Zhanel, GG | 1 |
| Hoban, DJ; Low, DE; Nichol, KA; Palatnick, L; Zhanel, GG | 1 |
| Hisanaga, T; Hoban, DJ; Nichol, K; Wierzbowski, A; Zhanel, GG | 1 |
| Chávez-Bueno, S; Fonseca-Aten, M; Gómez, AM; Hardy, RD; Hatfield, J; Jafri, HS; Katz, K; McCracken, GH; Mejías, A; Ramilo, O; Ríos, AM | 1 |
| Harms, JM; Tulkens, PM; Van Bambeke, F; Van Laethem, Y | 1 |
| Hammerschlag, MR; Sharma, R | 1 |
| Muller-Serieys, C | 1 |
| Lawrence, LE | 1 |
| Alder, J; Brazzale, A; Cao, Z; Chu, DT; Clark, RF; Ewing, P; Flamm, R; Griesgraber, G; Li, L; Ma, Z; Meulbroek, J; Mitten, M; Nemoto, PA; Nilius, AM; Or, YS; Phan, LT; Plattner, JJ; Rupp, MJ; Shortridge, VD; Wang, S; Yong, H; Zhang, S; Zhang, X; Zhong, P | 1 |
| Kim, M; Nicolau, DP; Nightingale, CH; Xuan, D; Ye, M | 1 |
| Almer, LS; Beyer, JM; Cao, Z; Doktor, SZ; Flamm, RK; Ramer, NC; Shortridge, VD; Zhong, P | 1 |
| Casellas, JM; Gliosca, L; Tomé, G; Visser, M | 1 |
| Flamm, RK; Hensey-Rudloff, DM; Nilius, AM; Reimann, MA | 1 |
| Fluit, AC; Milatovic, D; Schmitz, FJ; Schwarz, S; Verhoef, J | 1 |
6 review(s) available for cyfluthrin and Infections, Respiratory
| Article | Year |
|---|---|
Cethromycin: a promising new ketolide antibiotic for respiratory infections.
Topics: Animals; Anti-Bacterial Agents; Drugs, Investigational; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Ketolides; Microbial Sensitivity Tests; Respiratory Tract Infections | 2010 |
Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Ketolides; Macrolides; Respiratory Tract Infections; Streptococcus pneumoniae | 2003 |
Ketolides: pharmacological profile and rational positioning in the treatment of respiratory tract infections.
Topics: Animals; Anti-Bacterial Agents; Binding Sites; Humans; Ketolides; Macrolides; Respiratory Tract Infections | 2008 |
Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Microbial Sensitivity Tests; Molecular Structure; Respiratory Tract Infections; Treatment Outcome | 2008 |
[Ketolides and oxazolidinones. Mechanisms of action and antibacterial spectrum].
Topics: Acetamides; Anti-Bacterial Agents; Erythromycin; Gram-Positive Bacterial Infections; Humans; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Respiratory Tract Infections; Streptococcus; Structure-Activity Relationship | 2000 |
ABT-773 (Abbott Laboratories).
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clinical Trials as Topic; Erythromycin; Humans; Ketolides; Respiratory Tract Infections; Structure-Activity Relationship | 2001 |
9 other study(ies) available for cyfluthrin and Infections, Respiratory
| Article | Year |
|---|---|
Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Canada; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fluoroquinolones; Humans; Indoles; Ketolides; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumococcal Infections; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae; Tigecycline | 2003 |
Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Canada; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Gram-Negative Bacterial Infections; Haemophilus influenzae; Humans; Influenza, Human; Ketolides; Longitudinal Studies; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moraxella catarrhalis; Respiratory Tract Infections; Tigecycline | 2003 |
Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
Topics: Airway Obstruction; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cephalosporins; Chemokines; Cytokines; Erythromycin; Ketolides; Lung; Mice; Mycoplasma pneumoniae; Plethysmography; Pneumonia, Mycoplasma; Respiratory Mechanics; Respiratory Tract Infections | 2004 |
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cell-Free System; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Mice; Models, Molecular; Protein Biosynthesis; Protein Synthesis Inhibitors; Rats; Respiratory Tract Infections; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Transcription, Genetic | 2001 |
Pharmacokinetics of ABT-773, a new semi-synthetic ketolide in neutropenic lung-infected mice: a population approach.
Topics: Administration, Oral; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Erythromycin; Female; Half-Life; Intestinal Absorption; Ketolides; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Neutropenia; Respiratory Tract Infections; Tissue Distribution | 2002 |
Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Ribosomes; Staphylococcus; Streptococcus | 2002 |
In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2002 |
Comparison of selection for mutants with reduced susceptibility to ABT-773, erythromycin and rifampicin in respiratory tract pathogens.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Culture Media; Erythromycin; Haemophilus influenzae; Ketolides; Microbial Sensitivity Tests; Mutation; Phenotype; Respiratory Tract Infections; Rifampin; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 2002 |
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Haemophilus influenzae; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus | 2002 |